Related Experiment Video

Updated: Dec 22, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
08:48

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19

Published on: February 16, 2022

3.3K

COVID-19 and clinical mimics. Correct diagnosis is the key to appropriate therapy

Kamal Kant Sahu1, Ajay Kumar Mishra2, Kevin Martin3

  • 1Department of Medicine, Saint Vincent Hospital, Worcester. drkksahu85@gmail.com.

Monaldi Archives for Chest Disease = Archivio Monaldi Per Le Malattie Del Torace
|May 9, 2020
PubMed

Insights

The COVID-19 pandemic overwhelmed healthcare systems globally. This paper discusses challenges in diagnosing shortness of breath and respiratory symptoms amid the crisis.

Area of Science:

  • Public Health
  • Infectious Diseases
  • Epidemiology

Background:

  • The COVID-19 pandemic caused a rapid global surge in cases, overwhelming healthcare infrastructure.
  • Hospitals faced immense pressure, with regular and critical care beds filled by COVID-19 patients and persons under investigation (PUI).

Observation:

  • Healthcare systems worldwide experienced unprecedented strain due to the rapid increase in Coronavirus disease 2019 (COVID-19) cases.
  • Bed occupancy in wards and intensive care units (ICUs) significantly increased, primarily due to COVID-19 confirmed cases and PUIs.

Findings:

  • The abstract highlights the critical challenges in managing patients presenting with shortness of breath and common upper respiratory symptoms during the COVID-19 pandemic.
  • Diagnostic and clinical approaches were significantly impacted by the overwhelming number of cases and the need to differentiate COVID-19 from other conditions.

Implications:

  • Understanding these challenges is crucial for optimizing patient care and resource allocation during pandemics.
  • Effective strategies are needed to navigate diagnostic uncertainty and clinical decision-making in overwhelmed healthcare settings.
  • This highlights the need for robust public health preparedness and adaptable healthcare strategies for future infectious disease outbreaks.

More Related Videos

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-208:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.0K
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
200
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
180
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
126
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K